Cell Therapeutics, Inc. (CTIC) Narrows Q2 Loss

July 28, 2011 6:45 AM
Cell Therapeutics, Inc. (NASDAQ: CTIC) reported Q2 EPS of ($0.14), versus ($0.48) reported last year.

Categories

Earnings